Abstract
Polymorphism is a molecule’s ability to possess altered physical crystalline structures and has become an active interest in pharmaceuticals due to its ability to influence a drug’s physical and chemical properties. Crystal stability and solubility are crucial in determining a drug’s pharmacokinetics and pharmacodynamics. Changes in these properties due to polymorphisms have contributed to recalls and modifications in industrial production. For this study, the effects of surface interactions with pharmaceuticals were examined through surface modification methodology using organic phosphonic and sulfonic acid self-assembled monolayers (SAMs) developed on a nickel or zinc oxide metal substrate. Drugs analyzed included carbamazepine, cimetidine, tolfenamic acid, and flufenamic acid. All drugs were thermodynamically applied to the reformed surface to aid in recrystallization. It was hypothesized and confirmed that intermolecular bonds, especially hydrogen bonds between the SAMs and pharmaceutical drugs, were the force that assisted in polymorph development. The study was successful in revealing multiple forms for each drug, including their commercial form and at least one additional form using micro FT-IR, Raman spectroscopy, and PXRD. Visual comparisons of crystal polymorphisms were performed with IR microscopy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.